Division of Urology, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan.
Eur J Surg Oncol. 2012 Jul;38(7):630-6. doi: 10.1016/j.ejso.2012.03.006. Epub 2012 Apr 10.
The objective of this study was to evaluate the prognostic significance of the extent of a tumor thrombus in renal cell carcinoma (RCC) involving the venous system.
This study included 135 consecutive RCC patients with a venous tumor thrombus undergoing radical nephrectomy and tumor thrombectomy between 1985 and 2009. These patients were classified based on the maximal level of the tumor thrombus extending into the venous system, as follows: group 1, renal vein; group 2, infradiaphragmatic; and group 3, supradiaphragmatic.
Of the 135 patients, 65, 49 and 21 were classified into groups 1, 2 and 3, respectively. The 1, 3 and 5-year cancer-specific survival (CSS) rates in these 135 patients were 89.2, 56.9 and 49.2%, respectively. Among several factors examined, tumor size, tumor grade, perirenal fat invasion and presence of metastasis, but not extent of tumor thrombus, were significantly associated with CSS on univariate analysis. Of these significant factors, only tumor size and presence of metastasis appeared to be independently related to CSS on multivariate analysis. When the patients without metastasis were analyzed separately, CSS in groups 2 and 3 was significantly poorer than that in group 1.
These findings suggest the absence of a significant prognostic impact of the level of the tumor thrombus in a complete cohort of RCC patients with a venous tumor thrombus; however, it is warranted to determine whether the level of the tumor thrombus has different effects on the prognosis according to the presence of metastatic diseases.
本研究旨在评估累及静脉系统的肾细胞癌(RCC)肿瘤血栓范围的预后意义。
本研究纳入了 1985 年至 2009 年间接受根治性肾切除术和肿瘤血栓切除术的 135 例连续 RCC 伴静脉肿瘤血栓患者。这些患者根据肿瘤血栓延伸至静脉系统的最大水平进行分类,如下:第 1 组,肾静脉;第 2 组,膈下;第 3 组,膈上。
135 例患者中,65、49 和 21 例分别归入 1、2 和 3 组。这 135 例患者的 1、3 和 5 年癌症特异性生存率(CSS)分别为 89.2%、56.9%和 49.2%。在检查的几个因素中,肿瘤大小、肿瘤分级、肾周脂肪侵犯和转移的存在,但不是肿瘤血栓的范围,在单因素分析中与 CSS 显著相关。在这些显著因素中,只有肿瘤大小和转移的存在在多因素分析中与 CSS 独立相关。当分析无转移的患者时,2 组和 3 组的 CSS 明显差于 1 组。
这些发现表明,在完整的伴有静脉肿瘤血栓的 RCC 患者队列中,肿瘤血栓水平对预后没有显著的影响;然而,需要确定根据转移性疾病的存在,肿瘤血栓水平对预后是否有不同的影响。